chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (196 patients received 0.25mL of Moderna Covid-19 Vaccine, Bivalent).    No concomitant medication was reported.    It was unknown if the patient had received any other vaccine 4 weeks prior to COVID-19 vaccine.  No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Follow-up received: Age group added and I narrative updated.
It felt like a drilling pain in my eye socket that no pain killer could take away. When I went outside, I felt like I was being blinded even with sunglasses on. I made an appointment with my primary care physician who gave me steroids to help dim the pain and sent me to the neurologist. He ran a blood test to for the shingles virus, that did come back positive. I was given pain medication; I was also given the medication acyclovir to combat the shingles virus that I am currently taking now. My vision is getting better, but the rest is taking it's time to heal.
Patient became short of breath, had chest pain, and nausea about 20 minutes after her second COVID vaccine
He developed a swollen, warm, erythematous and tender left arm after administration. It was roughing 48 hours post administration when he was evaluated by me and no  tenderness noted, no airway involvement, no evidence of abscess. He was afebrile when I saw him.
Excessive crying, "screaming" throughout the day on 7/3. Worsening of rash present that was present prior to vaccination.
pt presented to ED with SOB, cough, edema in LEs, low O2 sats; hx of HTN, CHF; tested positive for COVID; O2 requirements increased during hospital stay; placed on BiPAP but pt didn't tolerate well; DNR; comfort measures instituted; pt's condition declined and she expired in the hospital
Fever; chills; body aches; This is a spontaneous report from a contactable consumer, the patient.  A 74-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE lot number EL3247), via an unspecified route of administration on 22Jan2021 at 09:45 (at the age of 74-years-old) as a single dose in the left arm for COVID-19 vaccination. Medical history included a history of COVID-19 infection on an unspecified date. Concomitant medications included bupropion hydrochloride (WELLBUTRIN) 150 mg and "Larsortin" 50 mg. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unspecified date in Jan2021 the patient experienced fever, chills and body aches. The patient did not receive any treatment for the events. The clinical outcomes fever, chills and body aches were reported as not recovered. It was also reported that since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Patient began feeling anxious, chest tightness,  and tingling  after receiving moderna vaccine.  Rn supervisor and paramedics intervened. No medical intervention necessary. Patient was guided through breathing techniques.
HALF OF HER FACE PARALYZED; This spontaneous report received from a consumer concerned a female patient of unspecified age, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown, expiry: unknown) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, half of patient's face was paralyzed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of half of her face paralyzed was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210760291.; Sender's Comments: V0:20210760712- covid-19 vaccine ad26.cov2.s-HALF OF HER FACE PARALYZED . This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
no adverse affects reported; patients received doses of improperly stored Varivax; This spontaneous report was received from a health professional and refers to a patient of unknown gender and age. The patient's concurrent conditions, medical history, concomitant therapies, drug reaction and allergies were not reported.   On an unknown date in April 2019 (reported as 25-APR-2019 or 26-APR-2019), the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) subcutaneously, lot # R034396, expiration date 27-NOV-2020, (dose was not reported) for prophylaxis. Administered dose of vaccine experienced the temperature excursion of 38 degrees Fahrenheit for 72 hours. Sterile diluent was stored properly. There were no previous excursions reported. Data logger was not involved. No adverse effects was reported.  This is one of eleven reports from the same reporter.; Sender's Comments:  US-009507513-1904USA013210: US-009507513-1904USA013268: US-009507513-1904USA013269: US-009507513-1904USA013270: US-009507513-1904USA013272: US-009507513-1904USA013275: US-009507513-1904USA013276: US-009507513-1904USA013278: US-009507513-1904USA000187: US-009507513-1904USA000191:
left ear ringing; bad headache; nauseous; no energy; I don't feel well; This is a spontaneous report from a contactable other healthcare professional (patient). A 63-year-old female patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: Elo142), via an unspecified route of administration into the left arm on 14Jan2021 14:30 at a single dose for covid-19 immunisation. Medical history was reported as none. Patient was not pregnant. Concomitant medication included calcium (CALCIUM), vitamin d3 (VITAMIN D3) and monascus purpureus (RED YEAST RICE). On 14Jan2021, patient experienced bad headache, was nauseous, had no energy and was not feeling well. On 15Jan2021, patient also experienced left ear ringing. The patient received no treatment for the events reported. Outcome of events was recovering.
Tooth removed; This spontaneous case was reported by a consumer and describes the occurrence of TOOTH EXTRACTION (Tooth removed) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced TOOTH EXTRACTION (Tooth removed). The patient was treated with IBUPROFEN for Tooth extraction, at an unspecified dose and frequency. At the time of the report, TOOTH EXTRACTION (Tooth removed) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment: Antibiotics for tooth extraction
I started having what seems like menstrual bleeding and light cramping two weeks after my regular period ended (regular period ended 5/3/22). Metrorrhagia started 5/16/22 and has been light but steady for 11 days (still ongoing as of 5/27/22), which is at least twice as long as any regular period I have ever had as an adult. Intermenstrual spotting has never been this heavy or long-running. Cramping was most noticeable 5/21, 5/22, and 5/23.   I visited my regular gynecologist to discuss the symptoms and have an exam on 5/24/22. They performed ultrasounds and a pelvic exam. Nothing abnormal has been found with the IUD placement or other internal issues. I have been advised to consult my endocrinologist if symptoms persist past my next period (due to begin 5/31/22). Bleeding currently persists, cramping does not.
This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Dose) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 10-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Dose). On 10-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Received Expired Dose) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was provided. No treatment medication was provided.
Developed fever 103 with diffuse sweats x 24 hrs, irritability x 48 hrs, 7 days after vaccinations.  Rash broke out about 24 hrs after fever broke - macular/papular at hairline and trunk.  Lesser over arms & legs.  Rash resolved in  48 hrs.  Symptomatic treatment per parents who are both family practice physicians.
Attendee voice complaints of dizziness and nausea 5 minutes after the vaccine administration.  Vomited x 1.  Skin cool and clammy.  10 minutes later the attendee was feeling much better and was asymptomatic.  Blood pressure was 98/70 when the adverse reaction occurred.
Red spot at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Red spot at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Red spot at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Red spot at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications reported. No treatment information provided.
Breakthrough case admission after 2 vaccines Moderna 2/26/21 Lot# 010A21A;  Moderna 3/26/21 Lot# 018B21A
Head aches that comes and goes; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Jun-2021 and was forwarded to Moderna on 11-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Head aches that comes and goes) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Head aches that comes and goes). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Headache, at a dose of 1 UNK. At the time of the report, HEADACHE (Head aches that comes and goes) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.     Concomitant medication was not provided.
Chest pain, SOB, worsening kidney disease, elevated Ddimer, Admitted to the hospital for observbation.  Follow up with cardiology
mild reaction to the Moderna COVID-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (mild reaction to the Moderna COVID-19 vaccine) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028620A) for COVID-19 vaccination.     Concomitant products included PREDNISONE and FAMOTIDINE (PEPCID [FAMOTIDINE]) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (mild reaction to the Moderna COVID-19 vaccine). At the time of the report, VACCINATION COMPLICATION (mild reaction to the Moderna COVID-19 vaccine) outcome was unknown.            No treatment information was provided by the reporter.   This case was linked to MOD-2021-291124 (Patient Link).
No pregnancy scares following HPV vaccine, became pregnant in May of 2016 and lost the baby in 07/2016. Was pregnant again in February 2017 and lost the baby. met with a fertility clinic they found nothing was wrong and suggested IVF. Got a second opinion and discovered that my ovaries were not producing mature eggs. I was prescribed clomid and egg growth was monitored. After three cycles and three medication dose increases we were successful in having a full term pregnancy born 08/2019.
Swollen injection site, large red painful area around injection site (6 inches across), headache, tender not just at injection site- but tender armpit of that arm, chills, fatigue lasting one week. At this time skin around injection site is still slightly red and itchy. My husband who was vaccinated at the same time had a different reaction. Besides a painful injection site, he experienced fever, chills, headache, and threw-up the morning after his vaccination, but got over everything quicker than I did.
I experienced throat swelling itching and hives as a result of my covid vaccine. The vaccine was given 1/6, symptoms occurred 1/7 overnight.
Initial information received on 18-Oct-2018 regarding an unsolicited valid non-serious case received from a consumer. This case involves a 73 years old female patient who experienced indentation in arm below the injection site, tired and about an inch and half below the injection site got a bright red spot about the size of a penny form, while she received vaccine FLUZONE HIGH DOSE. The patient's past vaccination(s) included FLU VACCINE in 2006. The patient's past medical history, medical treatment(s) and family history were not provided. On 27-Sep-2018, the patient received a dose of suspect FLUZONE HIGH DOSE lot number not reported (dose, expiry date, route and site of administration were unknown). On an unknown date, the patient developed a non-serious indentation in arm below the injection site, tired and about an inch and half below the injection site got a bright red spot about the size of a penny form (vaccination site inflammation) following the administration of FLUZONE HIGH DOSE. Other relevant tests included no lab data. Final diagnosis was about an inch and half below the injection site got a bright red spot about the size of a penny form, tired and indentation in arm below the injection site. It was not reported if the patient received a corrective treatment. The outcome of the event was not reported. List of documents held by sender- none.
Information has been received from a consumer concerning her 86 year old husband with diabetes and hypertension and a history of brain tumor. No known drug allergies/drug reactions, who on 14-NOV-2008 was vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck) (Lot # not reported). It was reported that the patient had shingles four months prior to the vaccination. It was reported that the patient was still having pain, tingling and burning where the shingles were following vaccination. A laboratory work was performed (results not provided). It was reported that the patient had not recovered at the time of the report. The patient sought unspecified medical attention. No further information is available.
This initial case was received from a consumer, who is also the patient's parent, on 29 January 2014. Of note, the reporter also experienced an adverse event following vaccination with FLUZONE (difficulty breathing, cough, throat swelling, chills, eyes swollen); the reporter (parent) events are captured in case 2014SA010247. A five-year-old female patient, with no reported concomitant medications or relevant medical history, received a first intramuscular injection of FLUZONE (lot number UH922AB) on 20 January 2014. Five days post-vaccination, on 25 January 2014, she began experiencing cough, runny nose, and fever. On 29 January 2014 she was seen by her physician, and rapid flu test was positive per the reporter. Outcome was not reported. Additional documents held by sender: None.
tested positive for COVID; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive for COVID) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No medical history.  The patient's past medical history included No adverse event. Concomitant products included VITAMINS NOS for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive for COVID). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) at an unspecified dose and frequency and NAPROXEN at an unspecified dose and frequency. At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive for COVID) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Mar-2021, COVID-19: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Headache; Nausea; Fatigue; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), NAUSEA (Nausea), FATIGUE (Fatigue) and CHILLS (Chills) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 30-Jan-2021.    On 08-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced HEADACHE (Headache), NAUSEA (Nausea), FATIGUE (Fatigue) and CHILLS (Chills). On 12-Apr-2021, NAUSEA (Nausea) and FATIGUE (Fatigue) had resolved. On 13-Apr-2021, HEADACHE (Headache) and CHILLS (Chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment information was not provided.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
5 minutes post injection, c/o burning sensation left upper arm down to elbow and left scapula.  No redness noted @ site.  Feels widespread across scapula.  No acute distress noted. No respiratory symptoms. Skin warm and dry. No rash noted.
Immediately after receiving GARDASIL (HPV) IM vaccine at (R) upper extremity which was preceded by the Hepatitis A IM vaccine at (L) upper extremity, this patient developed loss of consciousness and subsequent fall to the floor, his head protected by LPN. He proceeded to have clonic head and neck movements and rolling of eyes, simulating a brief seizure episode. This episode lasted approximately 5 secs. Patient placed in supine position with legs elevated with resulting gain of consciousness. He was observed for 30 minutes and then discharged home.
My son suffers from epilepsy and he has absent seizures. The next morning but 1:45 in the morning he had a grand Mal seizure which she has never had before we had to call 911 after administrating his emergency medication. They got to the hospital they murdered him for a couple hours and was sent home that 8:15 in the morning he had another seizure and wasn't coming out of it well I had a rushing up to the Hospital he did seem to have a low-grade fever which could have caused his seizures to be more pronounced. We stay there for a few hours just be monitored and we went home the same day after a updos on his seizure medications and some Tylenol for the fever. With the vaccine that can cause fevers and children with epilepsy can cause them to have a more of a prone seizure is what I'm thinking.
patient came in on 11/5/23 and reported that her left arm has been sore and is still tender to touch since she received her immunizations on 10/1/23. She can barely lift up her left arm past 45 degree. Says it is limiting her mobility and is painful
Redness and induration at the injection site and about 2cm surrounding area. Tx: Benadryl.
Sudden onset abdominal pain with sudden pallor, sleepiness, bradycardia to 57 BPM. No LOC, no vomiting. Irregular heart beat. Patient slow to recover and required transport via EMS to ER.
Vaccine #1 was Pfizer, Vaccine #2 was Moderna. The hospital called us 3 months later (July 9, 2021) to inform us of the error on their part!!!
flu like feeling; chills; very tired; muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like feeling), CHILLS (chills), FATIGUE (very tired) and MYALGIA (muscle aches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like feeling), CHILLS (chills), FATIGUE (very tired) and MYALGIA (muscle aches). At the time of the report, INFLUENZA LIKE ILLNESS (flu like feeling), CHILLS (chills), FATIGUE (very tired) and MYALGIA (muscle aches) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and gender. The patient was vaccinated with RECOMBIVAX HB (lot # 669597/0294AA and expiry date was 06-SEP-3014, route and dose were not reported) that was exposed to 25 Fahrenheit for an unknown period of time on 15-OCT-2012. No concomitant medications were reported. No adverse symptoms reported. This is one of several reports received from the same reporter. Follow up information was received from the licensed practical nurse who confirmed that none of the patients complained of any adverse experiences after receiving the above vaccines that had been stored incorrectly. Additional information is not expected.